Company record
Merck Sharp & Dohme LLC
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about Merck Sharp & Dohme LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Dec 31, 2025 | Class II | Merck Sharp & Dohme LLC Drug |
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Irelan… Presence of particulate matter: potential presence of metal particulates in the product. FDA notice D-0241-2026 |
| Dec 31, 2025 | Class II | Merck Sharp & Dohme LLC Drug |
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, T… Presence of particulate matter: potential presence of metal particulates in the product. FDA notice D-0242-2026 |